However, 3 in 4 patients failed screening for TTVR
Screening failure for transcatheter tricuspid valve replacement (TTVR) is high at 74%, mainly related to large tricuspid annular diameter, but tricuspid regurgitation (TR) reduction is superior with TTVR compared with tricuspid transcatheter edge-to-edge repair (T-TEER) and optimal medical therapy (OMT), a new registry analysis shows.